Literature DB >> 10029915

Serodiagnosis of Trypanosoma cruzi infection using the new particle gel immunoassay--ID-PaGIA Chagas.

A Rabello1, A O Luquetti, E F Moreira, M de F Gadelha, J A dos Santos, L de Melo, P Schwind.   

Abstract

The ID-Chagas test is a particle gel immunoassay (PaGIA). Red coloured particles are sensitised with three different synthetic peptides representing antigen sequences of Trypanosoma cruzi: Ag2, TcD and TcE. When these particles are mixed with serum containing specific antibodies, they agglutinate. The reaction mixture is centrifuged through a gel filtration matrix allowing free agglutinated particles to remain trapped on the top or distributed within the gel. The result can be read visually. In order to investigate the ability of the ID-PaGIA to discriminate negative and positive sera, 111 negative and 119 positive, collected in four different Brazilian institutions, were tested by each of the participants. All sera were previously classified as positive or negative according to results obtained with three conventional tests (indirect immunofluorescence, indirect hemaglutination, and enzyme linked immunosorbent assay). Sensitivity rates of ID-PaGIA varied from 95.7% to 97.4% with mean sensitivity of 96.8% and specificity rates varied from 93.8 to 98.8% with mean specificity of 94.6%. The overall Kappa test was 0.94. The assay presents as advantages the simplicity of operation and the reaction time of 20 min. In this study, ID-PaGIA showed to be highly sensitive and specific.

Entities:  

Mesh:

Year:  1999        PMID: 10029915     DOI: 10.1590/s0074-02761999000100016

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  2 in total

1.  Evaluation of a new particle gel immunoassay for determination of antibodies against Treponema pallidum.

Authors:  Bruno L Schmidt
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America.

Authors:  Carlos Ponce; Elisa Ponce; Elizabeth Vinelli; Alberto Montoya; Vilma de Aguilar; Antonio Gonzalez; Bianca Zingales; Rafael Rangel-Aldao; Mariano J Levin; Javan Esfandiari; Eufrosina S Umezawa; Alejandro O Luquetti; José Franco da Silveira
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.